Early breast cancer in young BRCA carriers: from diagnosis to treatment and survivorship Article Swipe
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1177/17588359251368733
Breast cancer is the most frequent malignancy among young women, with unique challenges particularly for carriers of BRCA pathogenic or likely pathogenic variants (PVs). Among them, the indication for intensive surveillance and risk-reducing surgeries is critical. In addition, special considerations on systemic treatment should be considered, including the use of targeted treatments like poly (adenosine diphosphate (ADP)-ribose) polymerase inhibitors. Moreover, the impact of anticancer treatments and risk-reducing surgeries on their ovarian reserve, pregnancy wish, and breastfeeding is a crucial aspect to be considered. Proper management of long-term toxicities, such as bone and cardiovascular health, as well as menopause-related symptoms, requires proper multidisciplinary care to optimize quality of life. This review examines the biological, clinical, therapeutic, and survivorship implications of breast cancer in young BRCA carriers, emphasizing differences between carriers of PVs in the BRCA1 and BRCA2 genes. Personalized strategies integrating genetic counseling, tailored surveillance and survivorship programs, as well as innovative therapies, are essential for improving prognosis and well-being in these young patients. Multidisciplinary care and further academic research efforts are critical to improve the management of breast cancer in young BRCA carriers.
Related Topics
- Type
- review
- Language
- en
- Landing Page
- https://doi.org/10.1177/17588359251368733
- OA Status
- gold
- References
- 121
- OpenAlex ID
- https://openalex.org/W4414310433
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4414310433Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1177/17588359251368733Digital Object Identifier
- Title
-
Early breast cancer in young BRCA carriers: from diagnosis to treatment and survivorshipWork title
- Type
-
reviewOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-09-01Full publication date if available
- Authors
-
Roberto Borea, Luca Arecco, Simone Nardin, Ezequiel Lozano Chiappe, Chiara Lanzavecchia, M. Fragio Gil, Arianna Meacci, Giang Pham Hoang, Luiza Nardin Weis, Luciana de Moura Leite, Valentina Eva Klocker, Pedro Freire, Nicole Brunetti, Lucia Trevisan, Giulia Buzzatti, Stefano Spinaci, Matteo LambertiniList of authors in order
- Landing page
-
https://doi.org/10.1177/17588359251368733Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1177/17588359251368733Direct OA link when available
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
121Number of works referenced by this work
Full payload
| id | https://openalex.org/W4414310433 |
|---|---|
| doi | https://doi.org/10.1177/17588359251368733 |
| ids.doi | https://doi.org/10.1177/17588359251368733 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/40979227 |
| ids.openalex | https://openalex.org/W4414310433 |
| fwci | 0.0 |
| type | review |
| title | Early breast cancer in young BRCA carriers: from diagnosis to treatment and survivorship |
| biblio.issue | |
| biblio.volume | 17 |
| biblio.last_page | 17588359251368733 |
| biblio.first_page | 17588359251368733 |
| topics[0].id | https://openalex.org/T10769 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.9997000098228455 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1311 |
| topics[0].subfield.display_name | Genetics |
| topics[0].display_name | BRCA gene mutations in cancer |
| topics[1].id | https://openalex.org/T12829 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9926000237464905 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2740 |
| topics[1].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[1].display_name | Advanced Breast Cancer Therapies |
| topics[2].id | https://openalex.org/T11914 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9926000237464905 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2730 |
| topics[2].subfield.display_name | Oncology |
| topics[2].display_name | PARP inhibition in cancer therapy |
| is_xpac | False |
| apc_list.value | 2300 |
| apc_list.currency | USD |
| apc_list.value_usd | 2300 |
| apc_paid.value | 2300 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 2300 |
| language | en |
| locations[0].id | doi:10.1177/17588359251368733 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S41085503 |
| locations[0].source.issn | 1758-8340, 1758-8359 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1758-8340 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Therapeutic Advances in Medical Oncology |
| locations[0].source.host_organization | https://openalex.org/P4310320017 |
| locations[0].source.host_organization_name | SAGE Publishing |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320017 |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Therapeutic Advances in Medical Oncology |
| locations[0].landing_page_url | https://doi.org/10.1177/17588359251368733 |
| locations[1].id | pmid:40979227 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Therapeutic advances in medical oncology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/40979227 |
| locations[2].id | pmh:oai:doaj.org/article:14ef2f5e3b9a4f65a169105e2cd182cb |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].source.host_organization_lineage | |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Therapeutic Advances in Medical Oncology, Vol 17 (2025) |
| locations[2].landing_page_url | https://doaj.org/article/14ef2f5e3b9a4f65a169105e2cd182cb |
| locations[3].id | pmh:oai:europepmc.org:11253689 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S4306400806 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | Europe PMC (PubMed Central) |
| locations[3].source.host_organization | https://openalex.org/I1303153112 |
| locations[3].source.host_organization_name | European Bioinformatics Institute |
| locations[3].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[3].license | other-oa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/other-oa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12444075 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5012217732 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-5403-0916 |
| authorships[0].author.display_name | Roberto Borea |
| authorships[0].countries | IT |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I83816512 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I4210146472 |
| authorships[0].affiliations[1].raw_affiliation_string | Department of Medical Oncology, Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy |
| authorships[0].institutions[0].id | https://openalex.org/I4210146472 |
| authorships[0].institutions[0].ror | https://ror.org/04d7es448 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210146472, https://openalex.org/I4210153126 |
| authorships[0].institutions[0].country_code | IT |
| authorships[0].institutions[0].display_name | Ospedale Policlinico San Martino |
| authorships[0].institutions[1].id | https://openalex.org/I83816512 |
| authorships[0].institutions[1].ror | https://ror.org/0107c5v14 |
| authorships[0].institutions[1].type | education |
| authorships[0].institutions[1].lineage | https://openalex.org/I83816512 |
| authorships[0].institutions[1].country_code | IT |
| authorships[0].institutions[1].display_name | University of Genoa |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Roberto Borea |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy, Department of Medical Oncology, Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy |
| authorships[1].author.id | https://openalex.org/A5021765093 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-3818-0364 |
| authorships[1].author.display_name | Luca Arecco |
| authorships[1].countries | BE, IT |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I2801838318 |
| authorships[1].affiliations[0].raw_affiliation_string | Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Academic Trials Promoting Team, Bruxelles, Belgium |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I83816512 |
| authorships[1].affiliations[1].raw_affiliation_string | Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy |
| authorships[1].institutions[0].id | https://openalex.org/I2801838318 |
| authorships[1].institutions[0].ror | https://ror.org/05e8s8534 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I2801838318 |
| authorships[1].institutions[0].country_code | BE |
| authorships[1].institutions[0].display_name | Institut Jules Bordet |
| authorships[1].institutions[1].id | https://openalex.org/I83816512 |
| authorships[1].institutions[1].ror | https://ror.org/0107c5v14 |
| authorships[1].institutions[1].type | education |
| authorships[1].institutions[1].lineage | https://openalex.org/I83816512 |
| authorships[1].institutions[1].country_code | IT |
| authorships[1].institutions[1].display_name | University of Genoa |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Luca Arecco |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy, Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Academic Trials Promoting Team, Bruxelles, Belgium |
| authorships[2].author.id | https://openalex.org/A5063739859 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-6150-5895 |
| authorships[2].author.display_name | Simone Nardin |
| authorships[2].countries | IT |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I83816512 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy |
| authorships[2].affiliations[1].institution_ids | https://openalex.org/I4210146472 |
| authorships[2].affiliations[1].raw_affiliation_string | Department of Medical Oncology, Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy |
| authorships[2].institutions[0].id | https://openalex.org/I4210146472 |
| authorships[2].institutions[0].ror | https://ror.org/04d7es448 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210146472, https://openalex.org/I4210153126 |
| authorships[2].institutions[0].country_code | IT |
| authorships[2].institutions[0].display_name | Ospedale Policlinico San Martino |
| authorships[2].institutions[1].id | https://openalex.org/I83816512 |
| authorships[2].institutions[1].ror | https://ror.org/0107c5v14 |
| authorships[2].institutions[1].type | education |
| authorships[2].institutions[1].lineage | https://openalex.org/I83816512 |
| authorships[2].institutions[1].country_code | IT |
| authorships[2].institutions[1].display_name | University of Genoa |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Simone Nardin |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy, Department of Medical Oncology, Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy |
| authorships[3].author.id | https://openalex.org/A5045111172 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-0890-6854 |
| authorships[3].author.display_name | Ezequiel Lozano Chiappe |
| authorships[3].countries | IT |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210146472 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy |
| authorships[3].affiliations[1].institution_ids | https://openalex.org/I83816512 |
| authorships[3].affiliations[1].raw_affiliation_string | Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy |
| authorships[3].institutions[0].id | https://openalex.org/I4210146472 |
| authorships[3].institutions[0].ror | https://ror.org/04d7es448 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210146472, https://openalex.org/I4210153126 |
| authorships[3].institutions[0].country_code | IT |
| authorships[3].institutions[0].display_name | Ospedale Policlinico San Martino |
| authorships[3].institutions[1].id | https://openalex.org/I83816512 |
| authorships[3].institutions[1].ror | https://ror.org/0107c5v14 |
| authorships[3].institutions[1].type | education |
| authorships[3].institutions[1].lineage | https://openalex.org/I83816512 |
| authorships[3].institutions[1].country_code | IT |
| authorships[3].institutions[1].display_name | University of Genoa |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Edoardo Chiappe |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy, Department of Medical Oncology, Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy |
| authorships[4].author.id | https://openalex.org/A5098677463 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Chiara Lanzavecchia |
| authorships[4].countries | IT |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210146472 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy |
| authorships[4].affiliations[1].institution_ids | https://openalex.org/I83816512 |
| authorships[4].affiliations[1].raw_affiliation_string | Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy |
| authorships[4].institutions[0].id | https://openalex.org/I4210146472 |
| authorships[4].institutions[0].ror | https://ror.org/04d7es448 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210146472, https://openalex.org/I4210153126 |
| authorships[4].institutions[0].country_code | IT |
| authorships[4].institutions[0].display_name | Ospedale Policlinico San Martino |
| authorships[4].institutions[1].id | https://openalex.org/I83816512 |
| authorships[4].institutions[1].ror | https://ror.org/0107c5v14 |
| authorships[4].institutions[1].type | education |
| authorships[4].institutions[1].lineage | https://openalex.org/I83816512 |
| authorships[4].institutions[1].country_code | IT |
| authorships[4].institutions[1].display_name | University of Genoa |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Chiara Lanzavecchia |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy, Department of Medical Oncology, Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy |
| authorships[5].author.id | https://openalex.org/A5020367612 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | M. Fragio Gil |
| authorships[5].countries | IT |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210146472 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy |
| authorships[5].affiliations[1].raw_affiliation_string | Department of Medical Oncology, Hospital Universitario Parc Tauli, Sabadell, Spain |
| authorships[5].institutions[0].id | https://openalex.org/I4210146472 |
| authorships[5].institutions[0].ror | https://ror.org/04d7es448 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210146472, https://openalex.org/I4210153126 |
| authorships[5].institutions[0].country_code | IT |
| authorships[5].institutions[0].display_name | Ospedale Policlinico San Martino |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Mónica Fragío Gil |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Medical Oncology, Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy, Department of Medical Oncology, Hospital Universitario Parc Tauli, Sabadell, Spain |
| authorships[6].author.id | https://openalex.org/A5046023666 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-4989-2797 |
| authorships[6].author.display_name | Arianna Meacci |
| authorships[6].countries | IT |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210146472 |
| authorships[6].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy |
| authorships[6].affiliations[1].institution_ids | https://openalex.org/I116067653 |
| authorships[6].affiliations[1].raw_affiliation_string | Department of Translational and Precision Medicine, Tor Vergata University of Rome, Rome, Italy |
| authorships[6].institutions[0].id | https://openalex.org/I4210146472 |
| authorships[6].institutions[0].ror | https://ror.org/04d7es448 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210146472, https://openalex.org/I4210153126 |
| authorships[6].institutions[0].country_code | IT |
| authorships[6].institutions[0].display_name | Ospedale Policlinico San Martino |
| authorships[6].institutions[1].id | https://openalex.org/I116067653 |
| authorships[6].institutions[1].ror | https://ror.org/02p77k626 |
| authorships[6].institutions[1].type | education |
| authorships[6].institutions[1].lineage | https://openalex.org/I116067653 |
| authorships[6].institutions[1].country_code | IT |
| authorships[6].institutions[1].display_name | University of Rome Tor Vergata |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Arianna Meacci |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Department of Medical Oncology, Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy, Department of Translational and Precision Medicine, Tor Vergata University of Rome, Rome, Italy |
| authorships[7].author.id | https://openalex.org/A5036014119 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Giang Pham Hoang |
| authorships[7].countries | VN |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210109845 |
| authorships[7].affiliations[0].raw_affiliation_string | Department of Oncology, Vinmec International General Hospital, Hanoi, Vietnam |
| authorships[7].institutions[0].id | https://openalex.org/I4210109845 |
| authorships[7].institutions[0].ror | https://ror.org/01q2pxs68 |
| authorships[7].institutions[0].type | healthcare |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210109845 |
| authorships[7].institutions[0].country_code | VN |
| authorships[7].institutions[0].display_name | Vinmec International Hospital |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Giang Pham Hoang |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Department of Oncology, Vinmec International General Hospital, Hanoi, Vietnam |
| authorships[8].author.id | https://openalex.org/A5022466950 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-8134-8062 |
| authorships[8].author.display_name | Luiza Nardin Weis |
| authorships[8].affiliations[0].raw_affiliation_string | DASA Oncology, Brasilia, Brazil |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Luiza Nardin Weis |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | DASA Oncology, Brasilia, Brazil |
| authorships[9].author.id | https://openalex.org/A5049533636 |
| authorships[9].author.orcid | https://orcid.org/0000-0003-4620-081X |
| authorships[9].author.display_name | Luciana de Moura Leite |
| authorships[9].countries | BR |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I3019035496 |
| authorships[9].affiliations[0].raw_affiliation_string | Department of Medical Oncology, A.C. Camargo Cancer Center, São Paulo, Brazil |
| authorships[9].institutions[0].id | https://openalex.org/I3019035496 |
| authorships[9].institutions[0].ror | https://ror.org/03025ga79 |
| authorships[9].institutions[0].type | healthcare |
| authorships[9].institutions[0].lineage | https://openalex.org/I3019035496 |
| authorships[9].institutions[0].country_code | BR |
| authorships[9].institutions[0].display_name | AC Camargo Hospital |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Luciana de Moura Leite |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Department of Medical Oncology, A.C. Camargo Cancer Center, São Paulo, Brazil |
| authorships[10].author.id | https://openalex.org/A5087846346 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Valentina Eva Klocker |
| authorships[10].countries | AT |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I202276237 |
| authorships[10].affiliations[0].raw_affiliation_string | Department of Internal Medicine, Division of Oncology, Medical University of Graz, Graz, Austria |
| authorships[10].institutions[0].id | https://openalex.org/I202276237 |
| authorships[10].institutions[0].ror | https://ror.org/02n0bts35 |
| authorships[10].institutions[0].type | education |
| authorships[10].institutions[0].lineage | https://openalex.org/I202276237 |
| authorships[10].institutions[0].country_code | AT |
| authorships[10].institutions[0].display_name | Medical University of Graz |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Valentina Eva Klocker |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Department of Internal Medicine, Division of Oncology, Medical University of Graz, Graz, Austria |
| authorships[11].author.id | https://openalex.org/A5108832115 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-3618-3609 |
| authorships[11].author.display_name | Pedro Freire |
| authorships[11].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Oncologia D’Or, Recife, Brazil |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Pedro Freire |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Department of Medical Oncology, Oncologia D’Or, Recife, Brazil |
| authorships[12].author.id | https://openalex.org/A5060552186 |
| authorships[12].author.orcid | https://orcid.org/0000-0003-2487-248X |
| authorships[12].author.display_name | Nicole Brunetti |
| authorships[12].countries | IT |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I4210146472 |
| authorships[12].affiliations[0].raw_affiliation_string | Department of Radiology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy |
| authorships[12].affiliations[1].institution_ids | https://openalex.org/I83816512 |
| authorships[12].affiliations[1].raw_affiliation_string | Department of Experimental Medicine, University of Genoa, Genoa, Italy |
| authorships[12].institutions[0].id | https://openalex.org/I4210146472 |
| authorships[12].institutions[0].ror | https://ror.org/04d7es448 |
| authorships[12].institutions[0].type | healthcare |
| authorships[12].institutions[0].lineage | https://openalex.org/I4210146472, https://openalex.org/I4210153126 |
| authorships[12].institutions[0].country_code | IT |
| authorships[12].institutions[0].display_name | Ospedale Policlinico San Martino |
| authorships[12].institutions[1].id | https://openalex.org/I83816512 |
| authorships[12].institutions[1].ror | https://ror.org/0107c5v14 |
| authorships[12].institutions[1].type | education |
| authorships[12].institutions[1].lineage | https://openalex.org/I83816512 |
| authorships[12].institutions[1].country_code | IT |
| authorships[12].institutions[1].display_name | University of Genoa |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Nicole Brunetti |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Department of Experimental Medicine, University of Genoa, Genoa, Italy, Department of Radiology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy |
| authorships[13].author.id | https://openalex.org/A5059456796 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-8608-4342 |
| authorships[13].author.display_name | Lucia Trevisan |
| authorships[13].countries | IT |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I4210146472 |
| authorships[13].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Hereditary Cancer Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy |
| authorships[13].institutions[0].id | https://openalex.org/I4210146472 |
| authorships[13].institutions[0].ror | https://ror.org/04d7es448 |
| authorships[13].institutions[0].type | healthcare |
| authorships[13].institutions[0].lineage | https://openalex.org/I4210146472, https://openalex.org/I4210153126 |
| authorships[13].institutions[0].country_code | IT |
| authorships[13].institutions[0].display_name | Ospedale Policlinico San Martino |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Lucia Trevisan |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Department of Medical Oncology, Hereditary Cancer Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy |
| authorships[14].author.id | https://openalex.org/A5075500641 |
| authorships[14].author.orcid | https://orcid.org/0000-0003-0077-7795 |
| authorships[14].author.display_name | Giulia Buzzatti |
| authorships[14].countries | IT |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I4210146472 |
| authorships[14].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Hereditary Cancer Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy |
| authorships[14].institutions[0].id | https://openalex.org/I4210146472 |
| authorships[14].institutions[0].ror | https://ror.org/04d7es448 |
| authorships[14].institutions[0].type | healthcare |
| authorships[14].institutions[0].lineage | https://openalex.org/I4210146472, https://openalex.org/I4210153126 |
| authorships[14].institutions[0].country_code | IT |
| authorships[14].institutions[0].display_name | Ospedale Policlinico San Martino |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Giulia Buzzatti |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Department of Medical Oncology, Hereditary Cancer Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy |
| authorships[15].author.id | https://openalex.org/A5032081401 |
| authorships[15].author.orcid | https://orcid.org/0000-0002-9255-534X |
| authorships[15].author.display_name | Stefano Spinaci |
| authorships[15].affiliations[0].raw_affiliation_string | Chirurgia Senologica, Ospedale Villa Scassi, ASL3, Genova, Italy |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Stefano Spinaci |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Chirurgia Senologica, Ospedale Villa Scassi, ASL3, Genova, Italy |
| authorships[16].author.id | https://openalex.org/A5082293621 |
| authorships[16].author.orcid | https://orcid.org/0000-0003-1797-5296 |
| authorships[16].author.display_name | Matteo Lambertini |
| authorships[16].countries | IT |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I4210146472 |
| authorships[16].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi 10, Genova 16132, Italy |
| authorships[16].affiliations[1].institution_ids | https://openalex.org/I83816512 |
| authorships[16].affiliations[1].raw_affiliation_string | Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy |
| authorships[16].institutions[0].id | https://openalex.org/I4210146472 |
| authorships[16].institutions[0].ror | https://ror.org/04d7es448 |
| authorships[16].institutions[0].type | healthcare |
| authorships[16].institutions[0].lineage | https://openalex.org/I4210146472, https://openalex.org/I4210153126 |
| authorships[16].institutions[0].country_code | IT |
| authorships[16].institutions[0].display_name | Ospedale Policlinico San Martino |
| authorships[16].institutions[1].id | https://openalex.org/I83816512 |
| authorships[16].institutions[1].ror | https://ror.org/0107c5v14 |
| authorships[16].institutions[1].type | education |
| authorships[16].institutions[1].lineage | https://openalex.org/I83816512 |
| authorships[16].institutions[1].country_code | IT |
| authorships[16].institutions[1].display_name | University of Genoa |
| authorships[16].author_position | last |
| authorships[16].raw_author_name | Matteo Lambertini |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy, Department of Medical Oncology, Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi 10, Genova 16132, Italy |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1177/17588359251368733 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Early breast cancer in young BRCA carriers: from diagnosis to treatment and survivorship |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10769 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.9997000098228455 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1311 |
| primary_topic.subfield.display_name | Genetics |
| primary_topic.display_name | BRCA gene mutations in cancer |
| cited_by_count | 0 |
| locations_count | 4 |
| best_oa_location.id | doi:10.1177/17588359251368733 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S41085503 |
| best_oa_location.source.issn | 1758-8340, 1758-8359 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1758-8340 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Therapeutic Advances in Medical Oncology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320017 |
| best_oa_location.source.host_organization_name | SAGE Publishing |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320017 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Therapeutic Advances in Medical Oncology |
| best_oa_location.landing_page_url | https://doi.org/10.1177/17588359251368733 |
| primary_location.id | doi:10.1177/17588359251368733 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S41085503 |
| primary_location.source.issn | 1758-8340, 1758-8359 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1758-8340 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Therapeutic Advances in Medical Oncology |
| primary_location.source.host_organization | https://openalex.org/P4310320017 |
| primary_location.source.host_organization_name | SAGE Publishing |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320017 |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Therapeutic Advances in Medical Oncology |
| primary_location.landing_page_url | https://doi.org/10.1177/17588359251368733 |
| publication_date | 2025-09-01 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W4406431707, https://openalex.org/W3043318102, https://openalex.org/W2118498634, https://openalex.org/W2091350790, https://openalex.org/W2057949133, https://openalex.org/W2782723462, https://openalex.org/W1514520056, https://openalex.org/W4387568247, https://openalex.org/W4289778745, https://openalex.org/W2735097753, https://openalex.org/W4392741635, https://openalex.org/W2025546864, https://openalex.org/W4390575634, https://openalex.org/W3100475287, https://openalex.org/W3124119591, https://openalex.org/W2627871710, https://openalex.org/W2609350370, https://openalex.org/W4307401062, https://openalex.org/W2140563000, https://openalex.org/W3118983547, https://openalex.org/W2905048441, https://openalex.org/W4407873120, https://openalex.org/W2106542343, https://openalex.org/W2802287528, https://openalex.org/W2163324183, https://openalex.org/W2898759485, https://openalex.org/W2977642107, https://openalex.org/W2756272086, https://openalex.org/W3041642525, https://openalex.org/W2230661564, https://openalex.org/W3021389685, https://openalex.org/W2297982713, https://openalex.org/W4410202982, https://openalex.org/W2139434007, https://openalex.org/W2067962376, https://openalex.org/W2107859602, https://openalex.org/W2125765400, https://openalex.org/W2099535971, https://openalex.org/W2965640531, https://openalex.org/W3208938232, https://openalex.org/W1995777454, https://openalex.org/W2154356111, https://openalex.org/W2003047709, https://openalex.org/W4399865048, https://openalex.org/W1975443386, https://openalex.org/W3018973986, https://openalex.org/W4224213278, https://openalex.org/W2257960242, https://openalex.org/W3186560763, https://openalex.org/W3120046654, https://openalex.org/W4393874617, https://openalex.org/W2000197817, https://openalex.org/W2807418950, https://openalex.org/W4295422767, https://openalex.org/W3212362104, https://openalex.org/W3008697231, https://openalex.org/W2127227293, https://openalex.org/W2108565008, https://openalex.org/W2754449739, https://openalex.org/W2803428420, https://openalex.org/W2734897937, https://openalex.org/W4386493325, https://openalex.org/W4210322552, https://openalex.org/W3047848114, https://openalex.org/W3127482120, https://openalex.org/W3006930853, https://openalex.org/W4402551965, https://openalex.org/W4403640753, https://openalex.org/W2953287793, https://openalex.org/W4390972613, https://openalex.org/W4381332738, https://openalex.org/W4402034457, https://openalex.org/W4304084160, https://openalex.org/W3040333729, https://openalex.org/W2773549447, https://openalex.org/W4380730083, https://openalex.org/W3093760305, https://openalex.org/W2788106879, https://openalex.org/W2621271973, https://openalex.org/W2886477543, https://openalex.org/W2995593755, https://openalex.org/W4387825887, https://openalex.org/W4283694363, https://openalex.org/W4220775266, https://openalex.org/W2309969893, https://openalex.org/W4388856588, https://openalex.org/W4397008005, https://openalex.org/W4391637581, https://openalex.org/W4399992245, https://openalex.org/W3088686555, https://openalex.org/W4399705517, https://openalex.org/W2119632042, https://openalex.org/W3020224562, https://openalex.org/W2953303244, https://openalex.org/W4316042065, https://openalex.org/W1936611284, https://openalex.org/W2151249060, https://openalex.org/W3211899052, https://openalex.org/W3197040171, https://openalex.org/W3110951731, https://openalex.org/W4409429162, https://openalex.org/W3112777664, https://openalex.org/W2527255307, https://openalex.org/W4392592480, https://openalex.org/W2763439289, https://openalex.org/W2802421801, https://openalex.org/W3216816468, https://openalex.org/W4367833987, https://openalex.org/W4387889741, https://openalex.org/W3173897906, https://openalex.org/W3042601198, https://openalex.org/W4389433568, https://openalex.org/W4383343099, https://openalex.org/W2092746460, https://openalex.org/W1987753117, https://openalex.org/W3153195366, https://openalex.org/W4220810371, https://openalex.org/W4225966173, https://openalex.org/W4386531401, https://openalex.org/W2795832917, https://openalex.org/W4413373403 |
| referenced_works_count | 121 |
| abstract_inverted_index.a | 77 |
| abstract_inverted_index.In | 36 |
| abstract_inverted_index.as | 89, 94, 96, 147, 149 |
| abstract_inverted_index.be | 44, 81 |
| abstract_inverted_index.in | 121, 131, 159, 179 |
| abstract_inverted_index.is | 2, 34, 76 |
| abstract_inverted_index.of | 16, 49, 62, 85, 106, 118, 129, 176 |
| abstract_inverted_index.on | 40, 68 |
| abstract_inverted_index.or | 19 |
| abstract_inverted_index.to | 80, 103, 172 |
| abstract_inverted_index.PVs | 130 |
| abstract_inverted_index.and | 31, 65, 74, 91, 115, 134, 144, 157, 165 |
| abstract_inverted_index.are | 152, 170 |
| abstract_inverted_index.for | 14, 28, 154 |
| abstract_inverted_index.the | 3, 26, 47, 60, 111, 132, 174 |
| abstract_inverted_index.use | 48 |
| abstract_inverted_index.BRCA | 17, 123, 181 |
| abstract_inverted_index.This | 108 |
| abstract_inverted_index.bone | 90 |
| abstract_inverted_index.care | 102, 164 |
| abstract_inverted_index.like | 52 |
| abstract_inverted_index.most | 4 |
| abstract_inverted_index.poly | 53 |
| abstract_inverted_index.such | 88 |
| abstract_inverted_index.well | 95, 148 |
| abstract_inverted_index.with | 10 |
| abstract_inverted_index.Among | 24 |
| abstract_inverted_index.BRCA1 | 133 |
| abstract_inverted_index.BRCA2 | 135 |
| abstract_inverted_index.among | 7 |
| abstract_inverted_index.life. | 107 |
| abstract_inverted_index.their | 69 |
| abstract_inverted_index.them, | 25 |
| abstract_inverted_index.these | 160 |
| abstract_inverted_index.wish, | 73 |
| abstract_inverted_index.young | 8, 122, 161, 180 |
| abstract_inverted_index.(PVs). | 23 |
| abstract_inverted_index.Breast | 0 |
| abstract_inverted_index.Proper | 83 |
| abstract_inverted_index.aspect | 79 |
| abstract_inverted_index.breast | 119, 177 |
| abstract_inverted_index.cancer | 1, 120, 178 |
| abstract_inverted_index.genes. | 136 |
| abstract_inverted_index.impact | 61 |
| abstract_inverted_index.likely | 20 |
| abstract_inverted_index.proper | 100 |
| abstract_inverted_index.review | 109 |
| abstract_inverted_index.should | 43 |
| abstract_inverted_index.unique | 11 |
| abstract_inverted_index.women, | 9 |
| abstract_inverted_index.between | 127 |
| abstract_inverted_index.crucial | 78 |
| abstract_inverted_index.efforts | 169 |
| abstract_inverted_index.further | 166 |
| abstract_inverted_index.genetic | 140 |
| abstract_inverted_index.health, | 93 |
| abstract_inverted_index.improve | 173 |
| abstract_inverted_index.ovarian | 70 |
| abstract_inverted_index.quality | 105 |
| abstract_inverted_index.special | 38 |
| abstract_inverted_index.academic | 167 |
| abstract_inverted_index.carriers | 15, 128 |
| abstract_inverted_index.critical | 171 |
| abstract_inverted_index.examines | 110 |
| abstract_inverted_index.frequent | 5 |
| abstract_inverted_index.optimize | 104 |
| abstract_inverted_index.requires | 99 |
| abstract_inverted_index.research | 168 |
| abstract_inverted_index.reserve, | 71 |
| abstract_inverted_index.systemic | 41 |
| abstract_inverted_index.tailored | 142 |
| abstract_inverted_index.targeted | 50 |
| abstract_inverted_index.variants | 22 |
| abstract_inverted_index.Moreover, | 59 |
| abstract_inverted_index.addition, | 37 |
| abstract_inverted_index.carriers, | 124 |
| abstract_inverted_index.carriers. | 182 |
| abstract_inverted_index.clinical, | 113 |
| abstract_inverted_index.critical. | 35 |
| abstract_inverted_index.essential | 153 |
| abstract_inverted_index.improving | 155 |
| abstract_inverted_index.including | 46 |
| abstract_inverted_index.intensive | 29 |
| abstract_inverted_index.long-term | 86 |
| abstract_inverted_index.patients. | 162 |
| abstract_inverted_index.pregnancy | 72 |
| abstract_inverted_index.prognosis | 156 |
| abstract_inverted_index.programs, | 146 |
| abstract_inverted_index.surgeries | 33, 67 |
| abstract_inverted_index.symptoms, | 98 |
| abstract_inverted_index.treatment | 42 |
| abstract_inverted_index.(adenosine | 54 |
| abstract_inverted_index.anticancer | 63 |
| abstract_inverted_index.challenges | 12 |
| abstract_inverted_index.indication | 27 |
| abstract_inverted_index.innovative | 150 |
| abstract_inverted_index.malignancy | 6 |
| abstract_inverted_index.management | 84, 175 |
| abstract_inverted_index.pathogenic | 18, 21 |
| abstract_inverted_index.polymerase | 57 |
| abstract_inverted_index.strategies | 138 |
| abstract_inverted_index.therapies, | 151 |
| abstract_inverted_index.treatments | 51, 64 |
| abstract_inverted_index.well-being | 158 |
| abstract_inverted_index.biological, | 112 |
| abstract_inverted_index.considered, | 45 |
| abstract_inverted_index.considered. | 82 |
| abstract_inverted_index.counseling, | 141 |
| abstract_inverted_index.differences | 126 |
| abstract_inverted_index.diphosphate | 55 |
| abstract_inverted_index.emphasizing | 125 |
| abstract_inverted_index.inhibitors. | 58 |
| abstract_inverted_index.integrating | 139 |
| abstract_inverted_index.toxicities, | 87 |
| abstract_inverted_index.Personalized | 137 |
| abstract_inverted_index.implications | 117 |
| abstract_inverted_index.particularly | 13 |
| abstract_inverted_index.surveillance | 30, 143 |
| abstract_inverted_index.survivorship | 116, 145 |
| abstract_inverted_index.therapeutic, | 114 |
| abstract_inverted_index.(ADP)-ribose) | 56 |
| abstract_inverted_index.breastfeeding | 75 |
| abstract_inverted_index.risk-reducing | 32, 66 |
| abstract_inverted_index.cardiovascular | 92 |
| abstract_inverted_index.considerations | 39 |
| abstract_inverted_index.Multidisciplinary | 163 |
| abstract_inverted_index.menopause-related | 97 |
| abstract_inverted_index.multidisciplinary | 101 |
| cited_by_percentile_year | |
| countries_distinct_count | 5 |
| institutions_distinct_count | 17 |
| citation_normalized_percentile.value | 0.44192647 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |